Skip to main content
SpringerLink
Log in
Book cover

Handbuch der Psychopharmakotherapie pp 361–367Cite as

Neuroendokrinologie

  • Chapter

Auszug

Die drei großen Kommunikationssyteme im menschlichen Körper, das Nervensystem, das endokrine System und das Immunsystem, interagieren vielfältig. Bereits in den Schriften der antiken Medizin gibt es humoralpathologische Modellvorstellungen, nach denen die Sekretionen von Körpersäften und das menschliche Verhalten (Temperamente), z. B. schwarze Galle und melancholischer Charakter, einander bedingten. Die klinische (Psycho-) Neuroendokrinologie, die empirisch das Zusammenspiel von Hormonen, Gehirn und Verhalten beim gesunden und kranken Menschen untersucht, ist hingegen ein relativ junges Forschungsfeld. Erst im 20. Jahrhundert wurden die physiologischen Grundlagen etabliert, wie das zentrale Nervensystem (ZNS) durch die Wirkung verschiedenster Neurotransmitter das periphere Endokrinium über die Modulation der Sekretion humoraler hypothalamischer bzw. hypophysärer Botenstoffe steuert.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Aemi A, Traber R, Hock C et al (2004) Low-dose cortisol for symptoms of posttraumatic stress disorder. Am J Psychiatry 161: 1488–1490

    Article  Google Scholar 

  • Ancelin ML, Scali J, Ritchie K (2007) Hormonal therapy and depression: are we overlooking an important therapeutic alternative? J Psychom Res 62: 473–485

    Article  Google Scholar 

  • Arzt E, Holsboer F (2006) CRF signaling: molecular specificity for drug targeting in the CNS. Trends Pharmacol Sci 27: 531–538

    Article  PubMed  CAS  Google Scholar 

  • Bauer M, Heinz A, Whybrow PC (2002) Thyroid hormone, serotonin and mood: of synergy and significance in the adult brain. Mol Psychiatry 7: 140–156

    Article  PubMed  CAS  Google Scholar 

  • Bleuler M (1954) Endokrinologische Psychiatrie. Thieme, Stuttgart

    Google Scholar 

  • de Kloet ER, Joels M, Holsboer F (2005) Stress and the brain: from adaptation to disease. Nature Rev Neurosci 6: 463–475

    Article  CAS  Google Scholar 

  • DeBattista C, Belanoff J (2006) The us e of mifepristone in the treatment of neuropsychiatric disorders, Trends Endocrinol Metab 17: 117–121

    Article  PubMed  CAS  Google Scholar 

  • Dunn PJ (1998) Neuroendocrine challenge tests: what can we learn from them? In: Van de, Kar LD (ed) Methods in neuroendocrinology. Springer, Heidelberg, pp 205–233

    Google Scholar 

  • Fountoulakis KN, Kantartzis S, Siamouli M, Panagiotidis G, Kaprinis S, Lacovides A, Kaprinis G (2006) Peripheral thyroid dysfunction in depression. World J Biol Psychiatry 7: 131–137

    Article  PubMed  Google Scholar 

  • Grambsch P, Young EA, Meller WH (2004) Pulsatile luteinzing, hormone disruption in depression. Psychoneuroendocrinology 29: 825–829

    Article  PubMed  CAS  Google Scholar 

  • Heuser I, Yassouridis A, Holsboer F (1994) The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J Psychiatr Res 28: 341–356

    Article  PubMed  CAS  Google Scholar 

  • Holsboer F (1998) The endocrinology of mental disease. In: Grossman A (ed) Clinical endocrinology. Blackwell Science, Oxford, pp 1096–1113

    Google Scholar 

  • Holsboer F (1999) The rationale for corticotrophin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J Psychiatr Res 33: 181–214

    Article  PubMed  CAS  Google Scholar 

  • Holsboer F, Gerken A, von Bardeleben U, Grimm W, Stalla GK, Müller OA (1985) Relationship between pituitary responses to human corticotrophin-releasing factor and thyrotropin-releasing hormone in depressives and normal controls. Eur J Pharmacol 110: 153–154

    Article  PubMed  CAS  Google Scholar 

  • Jahn H, Schick M, Kiefer F, Kellner M, Yassouridis A, Wiedemann K (2004) Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial. Arch Gen Psychiatry 61: 1235–1244

    Article  PubMed  CAS  Google Scholar 

  • Jarrett DB, Kupfer DJ, Miewald JM, Grochocinski VJ, Franz B (1994) Sleep-related growth hormone secretion is persistently suppressed in women with recurrent depression: a preliminary longitudinal analysis. J Psychiatr Res 28: 211–223

    Article  PubMed  CAS  Google Scholar 

  • Kellner M, Yehuda R (1999) Do panic disorder and posttraumatic stress disorder share a common psychoneuroendocrinology? Psychoneuroendocrinology 24: 485–504

    Article  PubMed  CAS  Google Scholar 

  • Kellner M, Jahn H, Wiedemann K (2003) Natriuretic peptides and panic disorders: therapeutic prospects. Expert Rev Neurotherapeutics 3: 89–94

    Article  Google Scholar 

  • Kluge M, Schussler P, Weikel J et al (2006) Altered nocturnal growth hormone (GH) secretion in obsessive compulsive disorder. Psychoneuroendocrinology 31: 1098–1104

    Article  PubMed  CAS  Google Scholar 

  • Landgraf R (2006) The involvement of the vasopressin system in stress-related disorders. CNS Neurol Disord Drug Targets 5: 167–179

    PubMed  CAS  Google Scholar 

  • Loosen PT, Prange AJ Jr (1982) Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review. Am J Psychiatry 139 405–416

    PubMed  CAS  Google Scholar 

  • Malison RT, Anand A, Pelton GH et al (1999) Limited efficacy of ketoconazole in treatment-refractory major depression. J Clin Psychopharmacol 19: 466–470

    Article  PubMed  CAS  Google Scholar 

  • Malven PV (2000) Neurotransmitters as regulators of hypothalamic function. In: Conn PM, Freeman ME (eds) Neuroendocrinology in physiology and medicine. Humana Press, Totowa, NJ, pp 59–73

    Google Scholar 

  • Peeters BW, Tonnaer JA, Groen MB et al (2004) Glucocorticoid receptor antagonists: a new tool to investigate disorders characterized by cortisol hypersecretion. Stress 7: 233–241

    Article  PubMed  CAS  Google Scholar 

  • Schatzberg AF (2003) New approaches to managing psychotic depression. J Clin Psychiatry 64(Suppl 1): 19–23

    PubMed  CAS  Google Scholar 

  • Steiger A (2007) Neurochemical regulation of sleep. J Psychiatr Res 41: 537–352

    Article  PubMed  Google Scholar 

  • Wiedemann K, Kellner M (1994) Endocrine characterization of the new dopamine autoreceptor agonist roxindole. Exp Clin Endocrinol 102: 284–288

    Article  PubMed  CAS  Google Scholar 

  • Wiedemann K, von Bardeleben U, Holsboer F (1991) Influence of h-CRH and ACTH (1–14) upon spontaneous growth hormone secretion. Neuroendocrinology 54: 62–68

    Google Scholar 

  • Wiedemann K, Jahn H, Yassouridis A, Kellner M (2001) Anxiolytic-like effects of atrial natriuretic peptide upon cholecystokinin-tetrapeptide-induced panic attacks. Arch Gen Psychiatry 58: 371–377

    Article  PubMed  CAS  Google Scholar 

  • Wolkowitz OM, Reus VI (2003) Neurotransmitters, neurosteroids and neurotrophins: new models of the pathophysiology of depression. World J Biol Psychiatry 4: 98–102

    Article  PubMed  Google Scholar 

  • Wolkowitz OM, Reus VI, Chan T, Manfredl F, Raum W, Johnson R, Canick J (1999) Antiglucocorticoid treatment of depression; double-blind ketoconazole. Biol Psychiatry 45: 1070–1074

    Article  PubMed  CAS  Google Scholar 

  • Yehuda R (2002) Current status of cortisol findings in post-traumatic stress disorder. Psychiatr Clin N Am 25: 341–368

    Article  Google Scholar 

  • Young EA, Korszun A (2002) The hypothalamic-pituitary-gonadal axis in mood disorders. Endocrinol Metab Clin N Am 31: 63–78

    Article  CAS  Google Scholar 

  • Zobel AW, Nickel T, Kuenzel HE, Ackl N, Sonntag A, Ising M, Holsboer F (2000) Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. J Psychiatry Res 34: 171–181

    Article  CAS  Google Scholar 

Download references

Authors
  1. Michael Kellner
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Max-Planck-Institut für Psychiatrie, Kraepelinstraße 2-10, 80804, München

    Florian Holsboer

  2. Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum der Rheinisch-Westfälischen Technischen Hochschule Aachen, Pauwelsstraße 30, 52074, Aachen

    Gerhard Gründer

  3. Ehemals: Psychiatrische Klinik und Poliklinik der Johannes-Gutenberg-Universität Mainz, Untere Zahlbacher Straße 8, 55131, Mainz

    Otto Benkert

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Kellner, M. (2008). Neuroendokrinologie. In: Holsboer, F., Gründer, G., Benkert, O. (eds) Handbuch der Psychopharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68748-1_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-68748-1_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-20475-6

  • Online ISBN: 978-3-540-68748-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation